SurModics Inc. Announces $35 Million Share Repurchase Authorization

EDEN PRAIRIE, Minn.--(BUSINESS WIRE)--SurModics, Inc. (Nasdaq: SRDX), a leading provider of surface modification and drug delivery technologies to the healthcare industry, announced today that its Board of Directors has approved a share repurchase program, authorizing the company to purchase up to $35 million of its outstanding common stock.

MORE ON THIS TOPIC